← 返回

细胞因子激活的 CD8+ T 细胞来源的细胞外囊泡的抗肿瘤作用

英文原题:The antitumor effect of extracellular vesicles derived from cytokine-activated CD8+ T cells.

查看英文原题

The antitumor effect of extracellular vesicles derived from cytokine-activated CD8+ T cells.

PubMed 2024/11/04(内容时间) J Leukoc Biol Q2 · IF 3.4(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

细胞外囊泡(EVs)是由多种细胞类型分泌的纳米级膜颗粒,参与许多重要的细胞过程。近年来,来源于免疫细胞的EVs,如树突状细胞、CAR-T 细胞和NK 细胞,因其已知的直接和间接抗肿瘤活性而备受关注。

在此,我们报道了由细胞因子激活的CD8+ T(caCD8)细胞释放的EVs及其对癌细胞的细胞毒性。caCD8细胞在体外经抗CD3抗体和细胞因子混合物刺激CD8+ T细胞后能够释放EVs。分离得到的囊泡具有典型的EV特征,如椭圆形形态、30至200 nm的粒径分布以及CD81表达。

值得注意的是,caCD8-EVs在体外对多种癌细胞表现出细胞毒性。此外,机制分析表明,caCD8-EVs不仅含有典型的细胞毒性蛋白(即颗粒酶B和穿孔素),而且与caCD8细胞相比显著富集干扰素γ(IFNγ)。EV来源的IFNγ参与了EV诱导的癌细胞凋亡。

因此,我们的数据揭示了caCD8细胞分泌的EVs的抗肿瘤效应以及EV来源IFNγ的潜在作用。

展开英文摘要原文

Extracellular vesicles (EVs) are nano-sized membrane particles secreted by various cell types that are involved in many important cellular processes. Recently, EVs originating from immune cells, such as dendritic cells, chimeric antigen receptor T cells, and natural killer cells, have attracted much attention because of their known direct and indirect antitumor activity.

Here, we report the EVs released by cytokine-activated CD8+ T (caCD8) cells and its cytotoxicity against cancer cells. CaCD8 cells can release EVs following stimulation of CD8+ T cells with an anti-CD3 antibody and a cytokine cocktail ex vivo. The isolated vesicles have typical EV characteristics, such as an oval shape and a size distribution between 30 and 200 nm, as well as CD81 expression.

Notably, caCD8-EVs displayed cytotoxicity against various cancer cells in vitro.

Furthermore, mechanism analysis demonstrates that caCD8-EVs not only contain typical cytotoxic proteins (i. e. granzyme B and perforin), but also significantly enrich interferon γ (IFNγ) compared with caCD8 cells. EV-derived IFNγ participates in EV-induced apoptosis in cancer cells.

Therefore, our data reveal antitumor effects of EVs secreted from caCD8 cells and the potential role of the EV-derived IFNγ.

论文信息

作者
Zhang L、Meng Y、An Y、Yang X、Wei F、Ren X
单位
Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Huanhuxi Road, Tiyuanbei, Hexi District, Tianjin 300060, China.China
期刊
Journal of leukocyte biology2024 Nov 4
原文标识
PubMed 38753658 · DOI 10.1093/jleuko/qiae117